The world's first AI-based early lung cancer decision support software
Our platform helps clinicians to identify and track at-risk patients and make optimal clinical management decisions.
WHAT WE DO
We are a lung health company,
developing products to help clinicians in the management, diagnosis and care of patients.
WHO WE ARE
A team of award-winning machine learning, medical device and clinical experts who work with top hospitals, physicians and authors of lung cancer guidelines across Europe and US.
HOW WE CAN
Optellum has gathered the largest real-world dataset of CT scans and, using Artificial Intelligence and Machine Learning, developed a solution to enable clinicians to identify at-risk patients and to guide lung cancer management.
Latest News and events
PRESS RELEASE: Optellum Receives FDA Clearance for the World’s First AI-Powered Clinical Decision Support Software for Early Lung Cancer Diagnosis
Optellum named by the UK government as one of the top 100 digital health companies
Optellum’s year in review
Optellum expands its commercial team in readiness for US sales